A Randomized, Double-blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine
收藏Mendeley Data2024-05-17 更新2024-06-27 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004489/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare overall survival in participants with metastatic colorectal cancer treated with either ramucirumab and FOLFIRI or placebo and FOLFIRI.
创建时间：
2023-06-28
